TrialBlood2023

Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study.

David Belada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.